281 related articles for article (PubMed ID: 20978195)
1. MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma.
Voortman J; Goto A; Mendiboure J; Sohn JJ; Schetter AJ; Saito M; Dunant A; Pham TC; Petrini I; Lee A; Khan MA; Hainaut P; Pignon JP; Brambilla E; Popper HH; Filipits M; Harris CC; Giaccone G
Cancer Res; 2010 Nov; 70(21):8288-98. PubMed ID: 20978195
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression and clinical outcome of small cell lung cancer.
Lee JH; Voortman J; Dingemans AM; Voeller DM; Pham T; Wang Y; Giaccone G
PLoS One; 2011; 6(6):e21300. PubMed ID: 21731696
[TBL] [Abstract][Full Text] [Related]
3. microRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation.
Shen Y; Tang D; Yao R; Wang M; Wang Y; Yao Y; Li X; Zhang H
Med Oncol; 2013 Dec; 30(4):750. PubMed ID: 24198203
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis.
Ma X; Le Teuff G; Lacas B; Tsao MS; Graziano S; Pignon JP; Douillard JY; Le Chevalier T; Seymour L; Filipits M; Pirker R; Jänne PA; Shepherd FA; Brambilla E; Soria JC; Hainaut P;
J Thorac Oncol; 2016 Jun; 11(6):850-61. PubMed ID: 26899019
[TBL] [Abstract][Full Text] [Related]
5. Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy.
Cui EH; Li HJ; Hua F; Wang B; Mao W; Feng XR; Li JY; Wang X
Acta Pharmacol Sin; 2013 Feb; 34(2):309-13. PubMed ID: 22983388
[TBL] [Abstract][Full Text] [Related]
6. Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer.
Ma X; Rousseau V; Sun H; Lantuejoul S; Filipits M; Pirker R; Popper H; Mendiboure J; Vataire AL; Le Chevalier T; Soria JC; Brambilla E; Dunant A; Hainaut P;
Mol Oncol; 2014 May; 8(3):555-64. PubMed ID: 24495481
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
Filipits M; Pirker R; Dunant A; Lantuejoul S; Schmid K; Huynh A; Haddad V; André F; Stahel R; Pignon JP; Soria JC; Popper HH; Le Chevalier T; Brambilla E
J Clin Oncol; 2007 Jul; 25(19):2735-40. PubMed ID: 17602078
[TBL] [Abstract][Full Text] [Related]
8. miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy.
Wang F; Lou JF; Cao Y; Shi XH; Wang P; Xu J; Xie EF; Xu T; Sun RH; Rao JY; Huang PW; Pan SY; Wang H
Exp Mol Med; 2015 May; 47(5):e162. PubMed ID: 25952770
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
[TBL] [Abstract][Full Text] [Related]
10. Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy.
Hou LK; Ma YS; Han Y; Lu GX; Luo P; Chang ZY; Xie RT; Yang HQ; Chai L; Cai MX; Wu TM; Yu F; Qin SS; Lv ZW; Wu CY; Fu D
PLoS One; 2017; 12(1):e0170431. PubMed ID: 28141816
[TBL] [Abstract][Full Text] [Related]
11. Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.
Buhl IK; Santoni-Rugiu E; Ravn J; Hansen A; Christensen IJ; Jensen T; Pratt B; Askaa J; Jensen PB; Knudsen S; Sørensen JB
PLoS One; 2018; 13(3):e0194609. PubMed ID: 29566065
[TBL] [Abstract][Full Text] [Related]
12. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
[TBL] [Abstract][Full Text] [Related]
13. MiR-205 and MiR-375 microRNA assays to distinguish squamous cell carcinoma from adenocarcinoma in lung cancer biopsies.
Patnaik S; Mallick R; Kannisto E; Sharma R; Bshara W; Yendamuri S; Dhillon SS
J Thorac Oncol; 2015 Mar; 10(3):446-53. PubMed ID: 25695220
[TBL] [Abstract][Full Text] [Related]
14. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H
Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050
[TBL] [Abstract][Full Text] [Related]
15. [The importance of p53 and ras mutation as predictive markers for adjuvant chemotherapy in non-small-cell lung cancer].
Hirai Y; Shimizu Y; Oura S; Yoshimasu T; Ota F; Nakamura R; Naito K; Nishiguchi H; Hashimoto S; Okamura Y
Gan To Kagaku Ryoho; 2012 Mar; 39(3):381-4. PubMed ID: 22421763
[TBL] [Abstract][Full Text] [Related]
16. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.
Duncavage E; Goodgame B; Sezhiyan A; Govindan R; Pfeifer J
J Thorac Oncol; 2010 Nov; 5(11):1755-63. PubMed ID: 20975375
[TBL] [Abstract][Full Text] [Related]
17. [Expression of microRNA let-7a, miR-155, and miR-205 in tumor and tumor-adjacent histologically normal tissue in patients with non-small cell lung cancer].
Shikeeva AA; Kekeeva TV; Zavalishina LE; Andreeva YY; Zaletaev DV; Frank GA
Arkh Patol; 2016; 78(3):3-10. PubMed ID: 27296000
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer.
Li ZH; Zhang H; Yang ZG; Wen GQ; Cui YB; Shao GG
J Int Med Res; 2013 Oct; 41(5):1437-44. PubMed ID: 24065453
[TBL] [Abstract][Full Text] [Related]
19. miR-30b and miR-30c expression predicted response to tyrosine kinase inhibitors as first line treatment in non-small cell lung cancer.
Gu YF; Zhang H; Su D; Mo ML; Song P; Zhang F; Zhang SC
Chin Med J (Engl); 2013 Dec; 126(23):4435-9. PubMed ID: 24286402
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer.
Navarro A; Diaz T; Gallardo E; Viñolas N; Marrades RM; Gel B; Campayo M; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
J Surg Oncol; 2011 Apr; 103(5):411-5. PubMed ID: 21400525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
